XORTX THERAPEUTICS INC (XRTX)

CA98420Q3061 - Common Stock

1.2  +0.03 (+2.57%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
N/AN/A
EBITDA
YoY % growth
-36.92KN/A-176.75K-1.138M
-543.79%		-546.07K
52.01%		-1.027M
-88.11%		-2.603M
-153.38%		-10.232M
-293.14%		-5.906M
42.28%		N/A
-322.38%		N/A
-29.55%
EBIT
YoY % growth
-36.92K-204.64K
-454.28%		-193.53K
5.43%		-1.157M
-497.95%		-565.97K
51.09%		-1.042M
-84.19%		-2.616M
-150.90%		-10.291M
-293.43%		-6.046M
41.25%		N/A
-311.79%		N/A
-17.34%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/AN/AN/AN/AN/AN/A
-127.73%		N/A
85.41%		N/A
2.31%		N/A
-11.64%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth		-0.30
-15.38%
Revenue
Q2Q % growth		N/A
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		N/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 -1.24
-25.25%		-0.26-0.98-372.20%
Q4 2023
Q2Q % growth
85.41%		-0.26%
Q3 2023
Q2Q % growth
-8.41%		-0.26%
Q2 2023
Q2Q % growth		 -1.09
-0.83%		-2.271.1852.08%
Q1 2023
Q2Q % growth		 -0.99
57.69%		-2.091.1052.65%
Q4 2022
Q2Q % growth		 -1.80
-61.06%		-2.450.6526.66%
Q2 2022
Q2Q % growth		 -1.08 -2.171.0950.14%
Q1 2022
Q2Q % growth		 -2.34 -1.74-0.60-34.19%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
RevenueN/A N/A N/A N/A